Publications | PubMed=856461 Seeger R.C., Rayner S.A., Banerjee A., Chung H., Laug W.E., Neustein H.B., Benedict W.F. Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res. 37:1364-1371(1977) PubMed=7037175 Reynolds C.P., Reynolds D.A., Frenkel E.P., Smith R.G. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant. Cancer Res. 42:1331-1336(1982) DOI=10.1016/B978-0-12-008304-6.50015-4 Biedler J.L., Meyers M.B., Spengler B.A. Homogeneously staining regions and double minute chromosomes, prevalent cytogenetic abnormalities of human neuroblastoma cells. (In) Advances in cellular neurobiology, Vol. 4; Fedoroff S., Hertz L. (eds.); pp.267-307; Academic Press; New York (1983) PubMed=2535691 Ciccarone V.C., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49:219-225(1989) DOI=10.1016/B978-0-12-333530-2.50006-X Israel M.A., Thiele C.J. Tumor cell lines of the peripheral nervous system. (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York (1994) PubMed=7838528 Cheng N.C., Van Roy N., Chan A., Beitsma M., Westerveld A., Speleman F., Versteeg R. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10:291-297(1995) DOI=10.1007/0-306-46872-7_2 Thiele C.J. Neuroblastoma. (In) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York (1999) PubMed=15892104; DOI=10.1002/gcc.20198 Mosse Y.P., Greshock J., Margolin A.A., Naylor T., Cole K., Khazi D., Hii G., Winter C., Shahzad S., Asziz M.U., Biegel J.A., Weber B.L., Maris J.M. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43:390-403(2005) PubMed=16822308; DOI=10.1186/1471-2407-6-177 Dam V., Morgan B.T., Mazanek P., Hogarty M.D. Mutations in PIK3CA are infrequent in neuroblastoma. BMC Cancer 6:177.1-177.10(2006) PubMed=18082704; DOI=10.1016/j.jpedsurg.2007.08.026 Komuro H., Saihara R., Shinya M., Takita J., Kaneko S., Kaneko M., Hayashi Y. Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines. J. Pediatr. Surg. 42:2040-2045(2007) PubMed=18165268; DOI=10.2353/ajpath.2008.061263 Stock C., Bozsaky E., Watzinger F., Poetschger U., Orel L., Lion T., Kowalska A., Ambros P.F. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization. Am. J. Pathol. 172:203-214(2008) PubMed=18724359; DOI=10.1038/nature07261 Mosse Y.P., Laudenslager M., Longo L., Cole K.A., Wood A., Attiyeh E.F., Laquaglia M.J., Sennett R., Lynch J.E., Perri P., Laureys G., Speleman F., Kim C., Hou C.-P., Hakonarson H., Torkamani A., Schork N.J., Brodeur G.M., Tonini G.P., Rappaport E., Devoto M., Maris J.M. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930-935(2008) PubMed=18923523; DOI=10.1038/nature07398 Janoueix-Lerosey I., Lequin D., Brugieres L., Ribeiro A., de Pontual L., Combaret V., Raynal V., Puisieux A., Schleiermacher G., Pierron G., Valteau-Couanet D., Frebourg T., Michon J., Lyonnet S., Amiel J., Delattre O. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455:967-970(2008) PubMed=18923524; DOI=10.1038/nature07399 Chen Y.-Y., Takita J., Choi Y.L., Kato M., Ohira M., Sanada M., Wang L.-L., Soda M., Kikuchi A., Igarashi T., Nakagawara A., Hayashi Y., Mano H., Ogawa S. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455:971-974(2008) PubMed=20164919; DOI=10.1038/nature08768 Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R. Signatures of mutation and selection in the cancer genome. Nature 463:893-898(2010) PubMed=20655465; DOI=10.1016/j.cell.2010.06.004 Holzel M., Huang S.-D., Koster J., Ora I., Lakeman A., Caron H.N., Nijkamp W., Xie J., Callens T., Asgharzadeh S., Seeger R.C., Messiaen L.M., Versteeg R., Bernards R. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell 142:218-229(2010) PubMed=22213050; DOI=10.1002/ijc.27415 Gawecka J.E., Geerts D., Koster J., Caliva M.J., Sulzmaier F.J., Opoku-Ansah J., Wada R.K., Bachmann A.S., Ramos J.W. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int. J. Cancer 131:1556-1568(2012) |